Molecular epidemiology of Staphylococcus aureus in pediatric cystic fibrosis patients: a single-center study
Frontiers in Cellular and Infection Microbiology · 28.05.2026 · 16
DOI: 10.3389/fcimb.2026.1808334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 28.05.2026. Verfasst von Katarzyna Garbacz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Microbiology, Medical Faculty, Medical University of Gdansk, Gdansk, Poland. Hauptthemen laut MEDLINE: Cystic Fibrosis, Staphylococcus aureus, Staphylococcal Infections. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.
Abstract (Originalsprache)
Introduction
Staphylococcus aureus is a key respiratory pathogen in children with cystic fibrosis (CF). This study aimed to evaluate the prevalence and relatedness of spa types of S. aureus respiratory isolates from pediatric CF patients, grouped by age, and to assess their antimicrobial resistance.
Methods
A total of 165 S. aureus isolated from 82 patients from single-center and diagnosed with cystic fibrosis over a three-year period were analyzed. Molecular typing ( spa typing and SCC mec typing) and antimicrobial susceptibility testing were performed.
Results
Sixty-four spa types were identified, including five novel types, and the isolates were assigned to 11 multilocus sequence typing (MLST) clonal complexes, most frequently CC30, CC22, CC97, CC45, and CC15. In 67.1% of patients, only a single spa type was detected. In cases where multiple types were isolated from a single patient, 85.2% of the isolates were not clonally related. Macrolide and lincosamide resistance was common, particularly among adolescents aged 12–18 years, at rates of 67.4% and 60.9%, respectively. Resistance to fluoroquinolones, aminoglycosides, tetracyclines, and co-trimoxazole did not exceed 15%. MRSA was detected in 10.7% of patients and exclusively among those with monoclonal colonization.
Conclusion
The finding indicates that S. aureus colonization in pediatric CF patients is highly diverse and primarily individualized, with limited evidence of clonal transmission. Given the high prevalence of macrolide resistance-particularly among adolescents-long-term macrolide therapy should be carefully monitored, with periodic microbiological surveillance to mitigate resistance selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Microbiology, Medical Faculty, Medical University of Gdansk, Gdansk, Poland.
- Department of Medical Microbiology, Medical Faculty, Medical University of Gdansk, Gdansk, Poland.
- Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
- Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, Krakow, Poland.
Förderung
- Narodowe Centrum Nauki
Zitieren
APA
Garbacz, K., Piechowicz, L., Mroczkowska, A., Empel, J., Międzobrodzki, J., & Kosecka-Strojek, M. (2026). Molecular epidemiology of Staphylococcus aureus in pediatric cystic fibrosis patients: a single-center study. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1808334
Vancouver
Garbacz K, Piechowicz L, Mroczkowska A, Empel J, Międzobrodzki J, Kosecka-Strojek M. Molecular epidemiology of Staphylococcus aureus in pediatric cystic fibrosis patients: a single-center study. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1808334
BibTeX
@article{Garbacz2026,
author = {Garbacz, Katarzyna and Piechowicz, Lidia and Mroczkowska, Aneta and Empel, Joanna and Międzobrodzki, Jacek and Kosecka-Strojek, Maja},
title = {Molecular epidemiology of Staphylococcus aureus in pediatric cystic fibrosis patients: a single-center study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1808334}
}
EUVIMED